Synopsis
Synopsis
0
KDMF
0
VMF
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Ah 5158
2. Ah-5158
3. Ah5158
4. Albetol
5. Apo Labetalol
6. Apo-labetalol
7. Apolabetalol
8. Dilevalol
9. Hydrochloride, Labetalol
10. Labetalol
11. Labetalol, (r,r)-isomer
12. Labetolol
13. Normodyne
14. Presolol
15. R,r Labetalol
16. R,r-labetalol
17. Sch 19927
18. Sch-19927
19. Sch19927
20. Trandate
1. 32780-64-6
2. Labetalol Hcl
3. Amipress
4. Presdate
5. Normodyne
6. Trandate
7. Labetalol (hydrochloride)
8. Sch 15719w
9. Ah 5158a
10. Sch-15719w
11. 2-hydroxy-5-(1-hydroxy-2-((4-phenylbutan-2-yl)amino)ethyl)benzamide Hydrochloride
12. Ibidomide Hydrochloride
13. Labetalol Hydrochloride
14. Ah-5158a
15. 1gev3baw9j
16. Nsc-290312
17. 32780-64-6 (hcl)
18. Mls000069666
19. Ah-5158a Hydrochloride
20. Sch-15719w Hydrochloride
21. 2-hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]benzamide Hydrochloride
22. 5-(1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)salicylamide Monohydrochloride
23. Ah-5158 Hydrochloride;sch-15719w
24. Labetalol Hcl (mixture Of Diastereomers)
25. Labrocol
26. Pressalolo
27. Smr000058463
28. Ipolab
29. 2-hydroxy-5-(1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl)benzamide Hcl
30. 2-hydroxy-5-[1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl]benzamide Hydrochloride
31. 2-hydroxy-5-[1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl]benzamide;hydrochloride
32. 5-(1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)salicylamide Hydrochloride
33. 5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]salicylamide Hydrochloride
34. 5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]salicylamide Monohydrochloride
35. Benzamide, 2-hydroxy-5-(1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)-, Monohydrochloride
36. Dsstox_cid_24654
37. Dsstox_rid_80378
38. Dsstox_gsid_44654
39. Ccris 1086
40. Sr-01000000209
41. Einecs 251-211-1
42. Unii-1gev3baw9j
43. Nsc 290312
44. 2-hydroxy-5-(1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl)benzamide Hydrochloride
45. 2-hydroxy-5-(1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl)benzamide Hydrochloride
46. Normodyne (tn)
47. Trandate (tn)
48. Prestwick_290
49. Einecs 276-694-6
50. Mfcd00057663
51. Labetalolhydrochloride
52. Labetalol Hydrochloride [usan:usp:jan]
53. Ah-5158 Hydrochloride
54. La.beta.lol Hydrochloride
55. Opera_id_1625
56. Benzamide,monohydrochloride
57. Ncgc00016810-01
58. Salicylamide, Hydrochloride
59. Cas-32780-64-6
60. Salicylamide, 5-(1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)-, Hydrochloride
61. Schembl41230
62. 72487-34-4
63. Mls001148626
64. Mls002222197
65. Spectrum1503243
66. Chebi:6344
67. Chembl1200323
68. Dtxsid0044654
69. Amy8842
70. Hms1568h16
71. Hms1922m13
72. Pharmakon1600-01503243
73. 72487-35-5
74. Bcp13886
75. Ex-a4940
76. Hy-b1108
77. Labetalol Hydrochloride [mi]
78. Tox21_110623
79. Tox21_302725
80. Tox21_500687
81. Ccg-40314
82. Labetalol Hydrochloride (jp17/usp)
83. Labetalol Hydrochloride [jan]
84. Nsc290312
85. Nsc758438
86. S4291
87. Labetalol Hydrochloride [usan]
88. Akos015895575
89. Ac-1389
90. Ah-5158
91. Cs-4706
92. Labetalol Hydrochloride [mart.]
93. Labetalol Hydrochloride [vandf]
94. Lp00687
95. Nc00571
96. Nsc-758438
97. Ss-4219
98. Labetalol Hydrochloride [usp-rs]
99. Labetalol Hydrochloride [who-dd]
100. Ncgc00094044-01
101. Ncgc00094044-02
102. Ncgc00094044-03
103. Ncgc00094044-04
104. Ncgc00094044-05
105. Ncgc00256847-01
106. Ncgc00261372-01
107. (r*,r*)-(1)-5-(1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)salicylamide Monohydrochloride
108. Benzamide,2-hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]-, Hydrochloride(1:1)
109. Db-048265
110. Eu-0100687
111. Ft-0630564
112. Ft-0773231
113. Labetalol Hydrochloride [orange Book]
114. Sw196595-3
115. Labetalol Hydrochloride [ep Monograph]
116. D00600
117. Labetalol Hydrochloride [usp Monograph]
118. Labetalol Hydrochloride, >98% (tlc), Powder
119. 780l646
120. Normozide Component Labetalol Hydrochloride
121. Sr-01000000209-2
122. Sr-01000000209-7
123. Labetalol Hydrochloride Component Of Normozide
124. Q27252396
125. 2-hydroxy-5-(1-hydroxy-2-((4-phenylbutan-2-yl)amino)ethyl)benzamide Hcl
126. Labetalol Hydrochloride, European Pharmacopoeia (ep) Reference Standard
127. Labetalol Hydrochloride, United States Pharmacopeia (usp) Reference Standard
128. Labetalol Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
129. Benzamide, 2-hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]-, Hydrochloride (1:1)
130. Benzamide,2-hydroxy-5-[(1s)-1-hydroxy-2-[[(1r)-1-methyl-3-phenylpropyl]amino]ethyl]-,hydrochloride (1:1), Rel-
Molecular Weight | 364.9 g/mol |
---|---|
Molecular Formula | C19H25ClN2O3 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 8 |
Exact Mass | 364.1553704 g/mol |
Monoisotopic Mass | 364.1553704 g/mol |
Topological Polar Surface Area | 95.6 Ų |
Heavy Atom Count | 25 |
Formal Charge | 0 |
Complexity | 385 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Labetalol hydrochloride |
Drug Label | Labetalol HCl USP tablets are adrenergic receptor blocking agents that have both selective alpha1-adrenergic and non-selective beta-adrenergic receptor blocking actions in a single substance.Labetalol HCl USP is a racemate, chemically designated as 5... |
Active Ingredient | Labetalol hydrochloride |
Dosage Form | Tablet; Injectable |
Route | Injection; Oral |
Strength | 200mg; 300mg; 5mg/ml; 100mg |
Market Status | Prescription |
Company | Hospira; Gland Pharma; Sandoz; Watson Labs; Ivax Sub Teva Pharms; Eurohlth Intl; Par Form; Akorn |
2 of 2 | |
---|---|
Drug Name | Labetalol hydrochloride |
Drug Label | Labetalol HCl USP tablets are adrenergic receptor blocking agents that have both selective alpha1-adrenergic and non-selective beta-adrenergic receptor blocking actions in a single substance.Labetalol HCl USP is a racemate, chemically designated as 5... |
Active Ingredient | Labetalol hydrochloride |
Dosage Form | Tablet; Injectable |
Route | Injection; Oral |
Strength | 200mg; 300mg; 5mg/ml; 100mg |
Market Status | Prescription |
Company | Hospira; Gland Pharma; Sandoz; Watson Labs; Ivax Sub Teva Pharms; Eurohlth Intl; Par Form; Akorn |
Adrenergic beta-Antagonists
Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)
Sympathomimetics
Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. (See all compounds classified as Sympathomimetics.)
Adrenergic alpha-1 Receptor Antagonists
Drugs that bind to and block the activation of ADRENERGIC ALPHA-1 RECEPTORS. (See all compounds classified as Adrenergic alpha-1 Receptor Antagonists.)
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info :
Registration Country : Sweden
Brand Name : Trandate
Dosage Form : TABLET
Dosage Strength : 100 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Trandate
Dosage Form : SOLUTION FOR INJECTION
Dosage Strength : 5 MG / ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Trandate
Dosage Form : TABLET
Dosage Strength : 200 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Norway
Brand Name : The Tran Date
Dosage Form : Antic-calc Tablet, Film Coated
Dosage Strength : 100 mg
Packaging : Box
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : The Tran Date
Dosage Form : Antic-calc Tablet, Film Coated
Dosage Strength : 200 mg
Packaging : Box
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : The Tran Date
Dosage Form : Injection fluid, resolution
Dosage Strength : 5 mg/ml
Packaging : Ampoule
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Switzerland
Brand Name : Trandate
Dosage Form : Tabl
Dosage Strength : 100mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Brand Name : Trandate
Dosage Form : Tabl
Dosage Strength : 200mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Trandate Injection
Dosage Form : INJ
Dosage Strength : 5mg/1ml
Packaging : 20X5mg/1ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info :
Registration Country : Australia
Brand Name : Presolol 100
Dosage Form : tablet
Dosage Strength : 100 mg
Packaging : 100
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Sweden
Brand Name : Trandate
Dosage Form : TABLET
Dosage Strength : 100 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Trandate
Dosage Form : SOLUTION FOR INJECTION
Dosage Strength : 5 MG / ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Trandate
Dosage Form : TABLET
Dosage Strength : 200 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Norway
Brand Name : The Tran Date
Dosage Form : Antic-calc Tablet, Film Coated
Dosage Strength : 100 mg
Packaging : Box
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : The Tran Date
Dosage Form : Antic-calc Tablet, Film Coated
Dosage Strength : 200 mg
Packaging : Box
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : The Tran Date
Dosage Form : Injection fluid, resolution
Dosage Strength : 5 mg/ml
Packaging : Ampoule
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Switzerland
Brand Name : Trandate
Dosage Form : Tabl
Dosage Strength : 100mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Brand Name : Trandate
Dosage Form : Tabl
Dosage Strength : 200mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Norway
Brand Name : The Tran Date
Dosage Form : Injection fluid, resolution
Dosage Strength : 5 mg/ml
Packaging : Ampoule
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Italy
Brand Name : Trandate
Dosage Form : Labetalol 200Mg 30 Joined' Oral Use
Dosage Strength : 30 CPR 200 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Canada
Brand Name : APO-LABETALOL
Dosage Form : TABLET
Dosage Strength : 100MG
Packaging : 100
Approval Date :
Application Number : 2243538
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
Brand Name : APO-LABETALOL
Dosage Form : TABLET
Dosage Strength : 200MG
Packaging : 100
Approval Date :
Application Number : 2243539
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
Brand Name : LABETALOL HYDROCHLORIDE INJECTION USP
Dosage Form : SOLUTION
Dosage Strength : 5MG/ML
Packaging :
Approval Date :
Application Number : 2541505
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
Brand Name : LABETALOL HYDROCHLORIDE INJECTION
Dosage Form : SOLUTION
Dosage Strength : 5MG/ML
Packaging : 20ML/40ML
Approval Date :
Application Number : 2457040
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
Brand Name : LABETALOL HYDROCHLORIDE INJECTION USP
Dosage Form : SOLUTION
Dosage Strength : 5MG/ML
Packaging : 20ML
Approval Date :
Application Number : 2391090
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
Brand Name : LABETALOL HYDROCHLORIDE INJECTION USP
Dosage Form : SOLUTION
Dosage Strength : 5MG/ML
Packaging : 1X20ML
Approval Date :
Application Number : 2231689
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
Brand Name : LABETALOL HYDROCHLORIDE INJECTION USP
Dosage Form : SOLUTION
Dosage Strength : 5MG/ML
Packaging : 20ML/40ML
Approval Date :
Application Number : 2385120
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
Brand Name : TRANDATE
Dosage Form : TABLET
Dosage Strength : 100MG
Packaging : 100
Approval Date :
Application Number : 2106272
Regulatory Info :
Registration Country : Canada
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Canada
Brand Name : TRANDATE
Dosage Form : TABLET
Dosage Strength : 200MG
Packaging : 100
Approval Date :
Application Number : 2106280
Regulatory Info :
Registration Country : Canada
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Canada
Brand Name : RIVA-LABETALOL
Dosage Form : TABLET
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number : 2489414
Regulatory Info :
Registration Country : Canada
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Labetalol Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Labetalol Hydrochloride, including repackagers and relabelers. The FDA regulates Labetalol Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Labetalol Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Labetalol Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Labetalol Hydrochloride supplier is an individual or a company that provides Labetalol Hydrochloride active pharmaceutical ingredient (API) or Labetalol Hydrochloride finished formulations upon request. The Labetalol Hydrochloride suppliers may include Labetalol Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Labetalol Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Labetalol Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Labetalol Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Labetalol Hydrochloride DMFs exist exist since differing nations have different regulations, such as Labetalol Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Labetalol Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Labetalol Hydrochloride USDMF includes data on Labetalol Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Labetalol Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Labetalol Hydrochloride suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Labetalol Hydrochloride Drug Master File in Japan (Labetalol Hydrochloride JDMF) empowers Labetalol Hydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Labetalol Hydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Labetalol Hydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Labetalol Hydrochloride suppliers with JDMF on PharmaCompass.
A Labetalol Hydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Labetalol Hydrochloride Certificate of Suitability (COS). The purpose of a Labetalol Hydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Labetalol Hydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Labetalol Hydrochloride to their clients by showing that a Labetalol Hydrochloride CEP has been issued for it. The manufacturer submits a Labetalol Hydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Labetalol Hydrochloride CEP holder for the record. Additionally, the data presented in the Labetalol Hydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Labetalol Hydrochloride DMF.
A Labetalol Hydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Labetalol Hydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Labetalol Hydrochloride suppliers with CEP (COS) on PharmaCompass.
A Labetalol Hydrochloride written confirmation (Labetalol Hydrochloride WC) is an official document issued by a regulatory agency to a Labetalol Hydrochloride manufacturer, verifying that the manufacturing facility of a Labetalol Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Labetalol Hydrochloride APIs or Labetalol Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Labetalol Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Labetalol Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Labetalol Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Labetalol Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Labetalol Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Labetalol Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Labetalol Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Labetalol Hydrochloride suppliers with NDC on PharmaCompass.
Labetalol Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Labetalol Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Labetalol Hydrochloride GMP manufacturer or Labetalol Hydrochloride GMP API supplier for your needs.
A Labetalol Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Labetalol Hydrochloride's compliance with Labetalol Hydrochloride specifications and serves as a tool for batch-level quality control.
Labetalol Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Labetalol Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Labetalol Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Labetalol Hydrochloride EP), Labetalol Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Labetalol Hydrochloride USP).
LOOKING FOR A SUPPLIER?